Ready Capital Corporation 620 Senior Notes due 2026 RCB Q1 2026 Earnings Significant EPS Miss Highlights Challenges Marker Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Progresses CCNEP Q1 2026 Earnings EPS Surpasses Estimates by 74 Amid Stable Operations ODFL Q1 2026 Earnings EPS Surpasses Estimates Amid Strong Operational Performance TG Therapeutics Q1 2026 Earnings EPS Misses Expectations Despite Stock Gain China Pharma Holdings CPHI Q3 2011 Earnings EPS Miss Weighs on Sentiment